Medtronic (MDT) Net Cash Flow (2014 - 2026)

Medtronic has disclosed Net Cash Flow across 13 years of filings, most recently posting -$169.0 million for Q3 2026.

• In Q3 2026, Net Cash Flow rose 83.3% year-over-year to -$169.0 million; the TTM figure through Jul 2026 stood at $488.0 million (up 286.26% YoY), while the FY2026 annual figure was -$355.0 million, down 147.59% from the prior year.
• Net Cash Flow came in at -$169.0 million for Q3 2026 at Medtronic, down from $768.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $2.8 billion in Q4 2022 to a low of -$2.9 billion in Q2 2023.
• Average Net Cash Flow over 5 years is -$64.6 million, with a median of -$4.0 million recorded in 2024.
• Year-over-year, Net Cash Flow jumped 3036.84% in 2022 and slumped 25200.0% in 2025.
• Over 5 years, Net Cash Flow stood at $2.8 billion in 2022, then slumped by 94.73% to $147.0 million in 2023, then plunged by 46.26% to $79.0 million in 2024, then plunged by 39.24% to $48.0 million in 2025, then plunged by 452.08% to -$169.0 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$169.0 million in Q3 2026, $768.0 million in Q2 2026, and -$159.0 million in Q1 2026.